Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis

Foeldvari I., Klotsche J., Hinrichs B., Helmus N., Kasapcopur O., Adrovic A., ...More

ARTHRITIS CARE & RESEARCH, vol.74, no.3, pp.364-370, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 74 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.1002/acr.24499
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.364-370
  • Istanbul University Affiliated: Yes


Objective. Utilizing data obtained from a prospective, international, juvenile systemic sclerosis (SSc) cohort, the present study was undertaken to determine if pulmonary screening with forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLco) is sufficient to assess the presence of interstitial lung disease (ILD) in comparison to high-resolution computed tomography (HRCT) in juvenile SSc.